News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Akhil Santhosh: Atezolizumab and Nab-paclitaxel still remain as one of the options for mTNBC
everydayhealth.com
Dec 18, 2024, 03:40

Akhil Santhosh: Atezolizumab and Nab-paclitaxel still remain as one of the options for mTNBC

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on LinkedIn:

“Atezolizumab and Nab-paclitaxel still remain as one of the options for mTNBC, but we should be wary of these 2 negative studies

  1. IMpassion 131: the same atezolizumab combination with conventional paclitaxel didn’t show benefit
  2. IMpassion 132: atezolizumab and chemotherapy don’t work in early progressors.”

Akhil Santhosh: Atezolizumab and Nab-paclitaxel still remain as one of the options for mTNBC

More posts featuring Akhil Santhosh.

Akhil Santhosh atezolizumab Breast Cancer cancer mTNBC OncoDaily Oncology Paclitaxel
Special Coverage
Insight
Dec 18, 2024, 03:40
Akhil Santhosh: Atezolizumab and Nab-paclitaxel still remain as one of the options for mTNBC
Blog
Dec 18, 2024, 03:36
Marina Uchenik: Our Animated Patient Guide to Liver Cancer
Blog
Dec 18, 2024, 03:09
Sebastian Szmit: Happy to be an author of one of the most cited articles in ECS Journal Family
Blog
Dec 18, 2024, 03:04
Hannah Storm: Special snapshots from hosting the V Foundation BooYah research symposium
Insight
Dec 18, 2024, 02:49
Sebastian Szmit: Real-time health information via Cancer Survivor Smart Card
Blog
Dec 17, 2024, 23:36
Amol Akhade: Speaking for economics of precision oncology
Blog
Dec 17, 2024, 23:36
Scientific Achievements of Danish Cancer Institute in 2024
Science
Dec 17, 2024, 23:36
Sendurai Mani: The Power of Cancer Chimeras - A New Frontier in Cancer Research
Blog
Dec 17, 2024, 23:36
Cristian Massacesi: Working for a future where cancer is eliminated as a cause of death
Blog
Dec 17, 2024, 23:36
Richard Paxman: The road to scalp cooling reimbursement in the U.S.
Blog
Dec 17, 2024, 23:36
ESMO Ambassadors reporting on the latest Cancer Research in the past year from ESMO events
Blog
Dec 17, 2024, 23:36
Ravindran Kanesvaran: Evidence-based ESMO guidelines for Asian populations